Becton, Dickinson and Company
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Becton, Dickinson and Company
Patients who receive breast reconstructive surgery using some brands of acellular dermal matrix seem to have a higher risk of major complications than those whose surgeries did not use the mesh, says a safety alert from the US FDA.
FDA grants emergency use authorization to OTC COVID-19 testing products as it targets allowing workplaces, schools and communities to access tools needed to screen for the virus rapidly and accurately.
Some courts have kept jurors in product liability cases from hearing evidence that the US FDA awarded 510(k) clearance to the devices at issue. But a New Jersey state appeals court went against that trend, cancelling jury awards and ordering new trials in two pelvic mesh lawsuits.
Medtech Insight spoke to attorney Greg Dadika about mass tort litigation, including industry trends, how to find the right law firm, and when it’s the right time to settle a suit.